IL83872A0 - Pharmaceutical compositions comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist - Google Patents
Pharmaceutical compositions comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonistInfo
- Publication number
- IL83872A0 IL83872A0 IL83872A IL8387287A IL83872A0 IL 83872 A0 IL83872 A0 IL 83872A0 IL 83872 A IL83872 A IL 83872A IL 8387287 A IL8387287 A IL 8387287A IL 83872 A0 IL83872 A0 IL 83872A0
- Authority
- IL
- Israel
- Prior art keywords
- thromboxane
- antagonist
- pharmaceutical compositions
- phosphodiesterase inhibitor
- phosphodiesterase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863631294 DE3631294A1 (de) | 1986-09-13 | 1986-09-13 | Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL83872A0 true IL83872A0 (en) | 1988-02-29 |
Family
ID=6309586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL83872A IL83872A0 (en) | 1986-09-13 | 1987-09-11 | Pharmaceutical compositions comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0260527B1 (fr) |
| JP (1) | JPS6379838A (fr) |
| KR (1) | KR880003624A (fr) |
| AU (1) | AU597718B2 (fr) |
| DE (2) | DE3631294A1 (fr) |
| DK (1) | DK472487A (fr) |
| ES (1) | ES2033755T3 (fr) |
| GR (1) | GR3004969T3 (fr) |
| IL (1) | IL83872A0 (fr) |
| NZ (1) | NZ221779A (fr) |
| PH (1) | PH23553A (fr) |
| ZA (1) | ZA876806B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0306846A3 (fr) * | 1987-09-11 | 1990-05-02 | Dr. Karl Thomae GmbH | Combinaison synergique comprenant un inhibiteur de phosphodiestérase et un antagoniste de thromboxane-A2 et leur application resp. préparation |
| US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
| US6585995B1 (en) | 1999-09-21 | 2003-07-01 | Hanson Stephen R | Methods and compositions for treating platelet-related disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4291368A (en) * | 1979-03-30 | 1981-09-22 | Borg-Warner Corporation | Pulse-width modulated inverter system and method |
| EP0054132B1 (fr) * | 1980-12-12 | 1984-10-10 | Dr. Karl Thomae GmbH | Pyrimidones, leur préparation et médicaments les contenant |
| DE3049207A1 (de) * | 1980-12-27 | 1982-07-29 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel |
| US4568676A (en) * | 1983-11-25 | 1986-02-04 | Thomas Jefferson University | Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor |
-
1986
- 1986-09-13 DE DE19863631294 patent/DE3631294A1/de not_active Withdrawn
-
1987
- 1987-09-01 PH PH35759A patent/PH23553A/en unknown
- 1987-09-02 DE DE8787112773T patent/DE3777926D1/de not_active Expired - Fee Related
- 1987-09-02 EP EP87112773A patent/EP0260527B1/fr not_active Expired - Lifetime
- 1987-09-02 ES ES198787112773T patent/ES2033755T3/es not_active Expired - Lifetime
- 1987-09-10 DK DK472487A patent/DK472487A/da not_active Application Discontinuation
- 1987-09-11 JP JP62228239A patent/JPS6379838A/ja active Pending
- 1987-09-11 IL IL83872A patent/IL83872A0/xx unknown
- 1987-09-11 NZ NZ221779A patent/NZ221779A/xx unknown
- 1987-09-11 AU AU78296/87A patent/AU597718B2/en not_active Ceased
- 1987-09-11 ZA ZA876806A patent/ZA876806B/xx unknown
- 1987-09-12 KR KR870010125A patent/KR880003624A/ko not_active Application Discontinuation
-
1992
- 1992-06-18 GR GR920401303T patent/GR3004969T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR880003624A (ko) | 1988-05-28 |
| AU597718B2 (en) | 1990-06-07 |
| DE3631294A1 (de) | 1988-03-24 |
| JPS6379838A (ja) | 1988-04-09 |
| ZA876806B (en) | 1989-05-30 |
| DK472487A (da) | 1988-03-14 |
| DK472487D0 (da) | 1987-09-10 |
| PH23553A (en) | 1989-08-25 |
| NZ221779A (en) | 1990-03-27 |
| ES2033755T3 (es) | 1993-04-01 |
| GR3004969T3 (fr) | 1993-04-28 |
| AU7829687A (en) | 1988-03-17 |
| EP0260527A3 (en) | 1989-08-09 |
| DE3777926D1 (de) | 1992-05-07 |
| EP0260527A2 (fr) | 1988-03-23 |
| EP0260527B1 (fr) | 1992-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2222772B (en) | Pharmaceutical compositions | |
| GB2219940B (en) | Pharmaceutical compositions | |
| IL87721A0 (en) | Synergistic pharmaceutical combinations comprising a pde inhibitor and a thromboxane a2 antagonist | |
| IL96594A0 (en) | Pharmaceutical compositions containing an antiallergic compound and an antihistamine | |
| HU896876D0 (en) | Pharmaceutical compositions | |
| IL102372A0 (en) | Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist | |
| IL88734A0 (en) | Pharmaceutical compositions comprising a comt inhibitor | |
| IL83872A0 (en) | Pharmaceutical compositions comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist | |
| NZ223725A (en) | Benzodioxole derivatives and pharmaceutical compositions | |
| GB2217202B (en) | Trimelamol-containing pharmaceutical compositions | |
| GB8830406D0 (en) | Pharmaceutical compositions | |
| IE872190L (en) | Pharmaceutical compositions comprising¹dopamine-beta-hydroxylase inhibitors | |
| IE891769L (en) | A pharmaceutical containing tnf inhibitor | |
| GB8815508D0 (en) | Tablet compositions | |
| IL84260A0 (en) | Pharmaceutical compositions comprising a 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor | |
| GB8808830D0 (en) | Pharmaceutical compositions | |
| GB8822507D0 (en) | Pharmaceutical compositions | |
| ZA897139B (en) | Pharmaceutical compositions | |
| GB8822603D0 (en) | Pharmaceutical compositions | |
| GB8820265D0 (en) | Pharmaceutical compositions | |
| ZA893224B (en) | Pharmaceutical compositions | |
| GB8815444D0 (en) | Pharmaceutical compositions | |
| GB8826289D0 (en) | Pharmaceutical compositions | |
| GB8815443D0 (en) | Pharmaceutical compositions | |
| IE882176L (en) | Pharmaceutical compositions |